Skip to main content

BRS3 — Inflammation & Oxidative Stress

BRS3-1-1 - NF-kB Signalling Regulation​

(Turning Down Overactive Inflammatory Switches)

1. Mission & Overview​

Mission​

Regulate NF-κB transcriptional tone so pro-inflammatory gene programmes do not fire excessively.

Intervention Dominance: Not established — No principal intervention route established

Precursor tracing measures red-cell glutathione; NF-κB redox studies use experimental cells. Their combination does not establish human dietary intervention responsiveness. No route is ranked above another, because none is established.

Overview​

NF-κB helps cells translate immune signals into inflammatory gene programmes. Its activation and DNA binding are regulated at several steps, including inhibitor phosphorylation and glutathione-dependent redox control. [7] [11] [12] Keeping this response appropriate is the biological aim; suppressing every response is not an established health benefit.

  • Benefits: This mechanism governs inflammatory signalling rather than a proven nutrient treatment or clinical outcome. The reviewed experiments establish regulation of activation and DNA binding. [7] [11]
  • Implementation Notes: Cysteine and glycine have supported upstream roles through glutathione. Combined supplementation increased red-cell glutathione synthesis in older adults, but did not measure NF-κB or establish a food dose. [13]
  • Biological Relevance: Glutathione provision connects this PM to redox biology; NF-κB regulation remains distinct from glutathione synthesis and downstream cytokine-network outputs. [11] [12]

2. Primary Biological Effects​

NF-κB activation, DNA binding and redox-sensitive inflammatory gene regulation

3. Intervention Levers​

4. Mechanistic Basis​

Summary​

When inflammatory transcriptional programmes remain engaged, downstream cytokine and immune-signalling tone escalates. NF-κB is a principal upstream node through which those programmes are expressed within BRS3(FM1) - Anti-Inflammatory Signalling Tone.

4.1 Scientific Findings (3)​

Scientific Findings and their assessments are available in Evidence & Audit.

Summary​

IKK experiments establish an activation gate, while redox studies demonstrate glutathione-dependent regulation of kinase activity and DNA binding. Human precursor tracing supports glutathione provision, but does not measure NF-κB. Together these findings support a bounded upstream supply relationship, not a proven dietary anti-inflammatory effect.

5. BRS Pathways and Connections​

5.1 BRS Pathways​

  • None listed

5.2 Cross-BRS Mechanism Relationships​

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

5.3 Local BRS Mechanism Relationships​

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

7. Phenome Connections​

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Clarity — modulatesOpen Page →
Focus / Attention Stability — modulatesOpen Page →
Emotional Regulation — modulatesOpen Page →
Apprehensive Worry / Perseverative Thought — modulatesOpen Page →
Pleasure & Interest Capacity — modulatesOpen Page →
Stage 2A/2B dietary-target assessment — 23 October 2026

ENRICHED. NF-kB transcriptional activation, distinguished from upstream redox supply.

Admit the mixed-meal comparison only as a bounded SOP; the study directly measured mononuclear NF-kB DNA binding. Do not attribute the response to isolated fibre, orange juice or polyphenols, or treat upstream GSH as direct evidence of transcriptional regulation.

New implementation: 0 dietary-input admissions (0 completed Unset candidates), 1 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.

Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.

8. References​